A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2011
10/04/2011	US8029809 Bacteriocins and novel bacterial strains
10/04/2011	US8029808 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
10/04/2011	US8029807 Outer membrane vesicles and uses thereof
10/04/2011	US8029806 Method for diagnosing of Mycobacterium tuberculosis
10/04/2011	US8029805 Recombinant B. pseudomallei adhesin protein and methods and uses thereof
10/04/2011	US8029804 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
10/04/2011	US8029803 Chimeric antigens for eliciting an immune response
10/04/2011	US8029802 Vaccines against Japanese encephalitis virus and West Nile virus
10/04/2011	US8029801 HN epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
10/04/2011	US8029800 Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)
10/04/2011	US8029799 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma
10/04/2011	US8029798 Multivalent vaccine composition with mixed carrier
10/04/2011	US8029797 Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	US8029795 treatment of iron overload e.g. from a blood transfusion; an iron chelator, a targeting agent and a lipid carrier, e.g., a liposome; targeting the heart
10/04/2011	US8029794 Combining therapies targeting multiple toll-like receptors
10/04/2011	US8029792 TCR-independent activation of T cells
10/04/2011	US8029790 Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
10/04/2011	US8029789 Method for the mass production of immunoglobulin constant region
10/04/2011	US8029788 Variants of humanized anti-carcinoma MAb CC49
10/04/2011	US8029787 Method of diagnosing, monitoring, staging, imaging and treating various cancers
10/04/2011	US8029786 Antibodies against a peptide epitope of apolipoprotein B
10/04/2011	US8029785 Using polyclonal goose antibodies as therapeutic tool in preventing viral infection of birds and mammals
10/04/2011	US8029784 Method for the diagnosis and prognosis of malignant diseases
10/04/2011	US8029783 DR5 antibodies and articles of manufacture containing same
10/04/2011	US8029778 Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3
10/04/2011	US8029776 Cationic lipid-mediated enhancement of nucleic acid immunization of cats
10/04/2011	US8029770 Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer
10/04/2011	US8029739 Ultraviolet sanitation device
10/04/2011	CA2521038C Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
10/04/2011	CA2431199C Immunotherapeutic kit for the treatment of tumors
10/04/2011	CA2339850C A non-cytolytic recombinant hiv-1 vaccine
10/04/2011	CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
10/04/2011	CA2262819C Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
10/04/2011	CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
10/04/2011	CA2224075C Vectors for the diagnosis and treatment of solid tumors including melanoma
09/2011
09/30/2011	CA2735513A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
09/29/2011	WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof
09/29/2011	WO2011119979A2 Antibodies to muc16 and methods of use thereof
09/29/2011	WO2011119920A2 Cmv glycoproteins and recombinant vectors
09/29/2011	WO2011119888A2 N-cadherin: target for cancer diagnosis and therapy
09/29/2011	WO2011119842A1 Compositions and methods for treating neurological disorders
09/29/2011	WO2011119716A2 Flavivirus host range mutations and uses thereof
09/29/2011	WO2011119661A1 Anti-lrp6 antibodies
09/29/2011	WO2011119656A1 Anti-angiogenesis therapy for treating abdominal aortic aneurysm
09/29/2011	WO2011119628A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
09/29/2011	WO2011119595A1 Phage constructs, sequences and antigenic compositions for immunocontraception of animals
09/29/2011	WO2011119527A1 Papillomavirus virus-like particle or capsomere formulation and its use as microbicide
09/29/2011	WO2011119524A1 Novel targets for regulation of angiogenesis
09/29/2011	WO2011119487A2 Compositions and methods useful for stabilizing protein-containing formulations
09/29/2011	WO2011119174A1 Treating allergy with detoxified e. coli heat-labile enterotoxin
09/29/2011	WO2011118804A1 Novel anti-cd98 antibody and use thereof
09/29/2011	WO2011118779A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections
09/29/2011	WO2011118743A1 Hcv variant with high productivity of infectious hepatitis c virus, and use thereof
09/29/2011	WO2011117886A1 Bispecific monoclonal antibody capable of cross reacting with lethal factor (lf) and edema factor (ef), and neutralizing edema toxin (et) as well as lethal toxin (lt) of bacillus anthracis
09/29/2011	WO2011117848A1 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
09/29/2011	WO2011117844A2 Method for evaluation of multiple antibodies or multiple antigens in a single sample
09/29/2011	WO2011117648A2 Disulfide stabilised antibodies and fragments thereof
09/29/2011	WO2011117559A1 Proangiogenic compositions, method for preparing same, and uses thereof
09/29/2011	WO2011117507A1 Live vaccine for aviary diseases
09/29/2011	WO2011117506A2 Adjuvant diluents for live vaccines for pig diseases
09/29/2011	WO2011117408A1 Hiv vaccine
09/29/2011	WO2011117401A1 Use of pcsk9 as a vaccine for lowering cholesterol
09/29/2011	WO2011117330A1 Bispecific antibodies
09/29/2011	WO2011117328A1 Method and compositions to induce apoptosis of tumoral cells expressing shh
09/29/2011	WO2011116954A2 Prophylaxis of colorectal and gastrointestinal cancer
09/29/2011	WO2011091435A3 Methods of treating liver disease
09/29/2011	WO2011088215A3 Notch1 binding agents and methods of use thereof
09/29/2011	WO2011079902A3 Biological inhibitors of ror1 capable of inducing cell death
09/29/2011	WO2011056899A3 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
09/29/2011	WO2011050319A3 Inhibiting the deleterious effect of anthracyclines
09/29/2011	WO2011044570A3 Recombinant antibodies against h1n1 influenza
09/29/2011	WO2011044452A3 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
09/29/2011	WO2011034953A3 Lassa virus-like particles and methods of production thereof
09/29/2011	WO2011022725A9 Mimotopes of hiv and uses thereof
09/29/2011	WO2011004263A3 Conserved escherichia coli immunogens
09/29/2011	US20110239316 ANTI-cMET ANTIBODY
09/29/2011	US20110238003 Method for systemic drug delivery through the nail
09/29/2011	US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/29/2011	US20110236685 Therapeutic calcium phosphate particles and methods of manufacture and use
09/29/2011	US20110236489 Vaccine adjuvant combinations
09/29/2011	US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens
09/29/2011	US20110236471 Platinum complexes and methods for inhibiting tumor cell proliferation
09/29/2011	US20110236470 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
09/29/2011	US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/29/2011	US20110236468 Vaccine compositions
09/29/2011	US20110236461 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor
09/29/2011	US20110236429 Small Cationic Antimicrobial Peptides
09/29/2011	US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response
09/29/2011	US20110236426 Pharmaceutical product for up-dosing of allergy vaccine
09/29/2011	US20110236425 Anthrax vaccine formulation and uses thereof
09/29/2011	US20110236424 Treating allergy with detoxified e. coli heat-labile enterotoxin
09/29/2011	US20110236423 Immunogenic agents against burkholderia pseudomallei and/or burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from burkholderia pseudomallei
09/29/2011	US20110236422 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
09/29/2011	US20110236421 Flavivirus host range mutations and uses thereof
09/29/2011	US20110236420 Bluetongue virus recombinant vaccines and uses thereof
09/29/2011	US20110236419 Recombinant cdv compositions and uses thereof
09/29/2011	US20110236418 Materials and Methods for Improved Vaccination
09/29/2011	US20110236417 Vaccines comprising mutant attenuated influenza viruses
09/29/2011	US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof

1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 1823